Delivery Order SPE2DB24D3015-SPE2DB25FFXTK

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB24D1006|SPE2DB25FCDXF, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $14,177.66 Firm Fixed Price contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with the ID SPE2DB20D1004|SPE2DB25FNFGH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,133.81 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying...
This federal contract award, SPE2DB20D2104|SPE2DB25FMGBW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a ceiling value of $1,920.36 and a completion date of January 15, 2025. The contract was awarded on January 14,...
This federal contract award SPE2DB22D2206 | SPE2DB25FFR00 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML. The $7,728.76 Firm Fixed Price contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.42 firm fixed price delivery order is for the provision of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $10,004.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, and has an ultimate completion date of March 24, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNX90, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, and has a ceiling value of $19,258.31. The contract type is Delivery Order with a Firm Fixed Price pricing mechanism. The ultimate completion date is December 24, 2024. This award is not designated as a set-aside contract....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX UNOREADY 300 MG PEN 2ML. The award, valued at $3,126.41, has a firm fixed price and an ultimate completion date of August 19, 2024. The contract is not set aside. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML. The contract is a $13,711.87 firm fixed-price delivery order with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,547.33, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. This is a firm fixed-price delivery order contract with a completion date of July 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a large Indefinite Delivery...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXTK
    Delivery Order

This federal contract award, with an ID of SPE2DB24D3015|SPE2DB25FFXTK, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,324.82, for the purchase of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. The contract has an ultimate completion date of January 21, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/18/25, 2:00 PM